Have your say on the Federal Register of Legislation. Complete our annual survey and tell us about your experience using the Register.
The feedback form on the Register is currently unavailable. We apologise for any inconvenience.
This item is authorised by the following title:
Health Insurance Legislation Amendment (Listing of Selpercatinib) Determination 2026 (F2026L01001)
Health Insurance (Section 4BA - Pathologist-Determinable Services) Amendment (Administrative) Determination 2026 (F2026L00986)
Health Insurance (Section 4BA - Pathologist-Determinable Services) Amendment (Ribonucleic Acid Testing for Hepatitis C) Determination 2026 (F2026L00413)
Health Insurance Legislation Amendment (Listing of Futibatinib) Determination 2026 (F2026L00632)
View Explanatory Statement/s